Aura Biosciences Inc AURA
NASDAQ · United States · Health Technology
$6.09+0.05 (+0.83%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.48 | -0.38 | -28.0% | $0 | — | +0.6%$7.70→$7.75 |
| Q1 2026 | 2026-05-11 | -0.50 | -0.40 | -25.0% | — | — | -5.6%$8.40→$7.93 |
| Q4 2025 | 2026-03-30 | -0.37 | -0.43 | +14.0% | — | — | +6.7%$6.27→$6.69 |
| Q3 2025 | 2025-11-13 | -0.40 | -0.46 | +13.0% | — | — | -0.7%$5.57→$5.53 |
| Q4 2024 | 2025-03-24 | -0.52 | -0.44 | -18.2% | — | — | — |
| Q4 2023 | 2024-03-27 | -0.50 | -0.41 | -22.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.